Citizens Inc (CIA)
🔔 Watch stock
symbol.quality_heading
The business works in principle, but one material question is open. As long as it stays open, our findings do not carry a quality verdict.
Whoever buys today is betting that dozens of governments keep standing still and that the new whole life and final expense business outruns the endowment wave before the old renewal premiums run out — and pays price-to-book of 1.3 for it after a 70 percent rally. Whoever waits will see in the coming quarterly reports whether first year premiums keep growing double-digit and the international segment stabilizes its pre-tax income — at this trading volume, you rarely miss much at once. The decision is yours.
symbol.quality_note
The ticker sounds like an intelligence agency, the stock like a hidden gem: Citizens, Inc. (NYSE: CIA) registers just 2 mentions in 24 hours in our Reddit hype scanner (as of July 15, 2026) — and still gained about 70 percent over twelve months (data as of July 10, 2026). The Austin, Texas life insurer sells dollar policies to customers from Colombia to Taiwan. We read the annual reports (10-K) for 2024 and 2025 and the quarterly report (10-Q) as of March 31, 2026: not a cent of debt, two straight years of premium growth — but the company is not licensed as an insurer in a single one of its foreign markets, the highest wave of maturing endowment policies in its history is rolling through the books, and it has never paid a dividend in its entire life as a public company. Not investment advice — just the complete file on a stock that looks like a secret and reads like a disclosure.
Read the analysis
Stock Watch
This analysis is as of July 16, 2026. Stock Watch will tell you what's changed at CIA since then.
Later $1 a month per stock — signing up is free, and you'll be the first to know when it launches.
Appears in These Scanners
This stock currently matches 4 of our scanner strategies — each hit links to the scanner.
Only genuine hits from verified scanners count; pure ranking metrics (P/E, P/S, and similar, which just sort the whole universe) don't count as a hit. View all scanners
Trading Day
Key levels of the most recently completed trading day — not a live quote.
52-Week Range
Current price 4.70 $ — 35% of the range above the low.
Lowest and highest closing price over the last 52 weeks. The marker shows where the current price sits within that range: close to the high speaks for strength, close to the low for weakness.
Basics
Performance
Technical Indicators
Calculated from the price history · as of 08/03/2026
Valuation
Profitability
Balance Sheet & Safety
Growth
Dividend
This stock currently pays no dividend.
Quality & Screener
AI Rating
NeutralGeprüft am 16.07.2026 gegen die Geschäftsberichte (10-K) 2025 (eingereicht 12.03.2026) und 2024 (13.03.2025) sowie die vier jüngsten Quartalsberichte (10-Q, zuletzt zum 31.03.2026): In den ausgewerteten SEC-Filings von Citizens, Inc. findet sich kein wesentlicher firmenindividueller KI-Bezug. Beide 10-K erwähnen generative KI ausschließlich als Branchenkontext — der 10-K 2025 unter „Technology, Innovation and Digitization“ (Versicherer investierten branchenweit in digitale Vertriebswege, automatisiertes Underwriting, Analytik und generative KI), der 10-K 2024 unter „Technology Adoption“ (die KI-Entwicklung „fordere die Branche heraus“, man müsse den Wandel annehmen). Weder wird KI als Umsatzquelle beschrieben (die Produkte sind klassische Lebens-, Endowment- und Final-Expense-Policen) noch ein konkreter eigener operativer KI-Einsatz dokumentiert (das erwähnte datengestützte Underwriting bei CLOA nutzt „zusätzliche Medizin- und Labordaten Dritter“, ohne KI-Bezug), noch ein konkretes KI-Geschäftsrisiko fürs eigene Modell benannt — Branchen-Boilerplate ist nach dem Kriterienkatalog kein Bedroht-Beleg. Die vier 10-Q enthalten keinerlei KI-Erwähnungen. Negativ-Befund dokumentiert, daher „neutral“.
View the full file — quotes, sources, reviewed filings
„Insurers are investing in digital distribution capabilities, automated underwriting, advanced analytics, and generative artificial intelligence to improve customer experience, enhance agent productivity, and streamline operations."
Versicherer investieren in digitale Vertriebsfähigkeiten, automatisiertes Underwriting, fortgeschrittene Analytik und generative Künstliche Intelligenz, um das Kundenerlebnis zu verbessern, die Produktivität der Vermittler zu steigern und Abläufe zu verschlanken.
„Innovation and digital development strategies, including the use of generative AI, continue to evolve and impact all industries, including the insurance industry."
Innovations- und Digitalisierungsstrategien, einschließlich des Einsatzes generativer KI, entwickeln sich weiter und wirken sich auf alle Branchen aus, auch auf die Versicherungsbranche.
Filings Reviewed: 10-Q 2026-05-07 · 10-Q 2025-11-06 · 10-Q 2025-08-07 · 10-Q 2025-05-08 · 10-K 2026-03-12 · 10-K 2025-03-13
Rated on July 16, 2026 · How the Rating Is Built
Analysts & Price Target
The price target sits 27.7% above the current price.
Combined picture of the price targets and recommendations of every analyst covering the stock. Price targets are expectations for the next 12 months, not promises — and they often follow the price rather than predict it.
Next Reporting Date
- Expected Earnings per Share
- 0.07 $
Expected date of the next quarterly or annual figures. Dates do shift occasionally — only the invitation issued by the company is binding.
Revenue & Profit
Cash Flow
Balance Sheet
Margins
Per Share
Click the chart or tab into it, then use ← and → to step through the periods.
None of the selected stocks reports this metric. Pick another metric or switch between annual and quarterly.
· Total · per year
These companies report in different currencies — switch on “Indexed” or pick a margin for a fair comparison.
The figures could not be loaded right now.
Source: fundamental data
Quarterly Figures
| Quarter | EPS (Earnings Per Share) | EPS YoY (%) | Sales ($M) | Sales YoY (%) | Net Margin (%) | OCF ($M) | FCF ($M) |
|---|---|---|---|---|---|---|---|
| 2024: Q4 | 0.07 | -66.30 | 64 | -5.00 | 5.70 | 11 | 11 |
| 2025: Q1 | -0.03 | -135.70 | 56 | -3.60 | -2.90 | 1 | 1 |
| 2025: Q2 | 0.13 | 63.10 | 65 | 4.80 | 9.90 | 4 | 3 |
| 2025: Q3 | 0.05 | -13.40 | 63 | 1.70 | 3.80 | 5 | 5 |
| 2025: Q4 | 0.15 | 102.70 | 72 | 13.50 | 10.20 | 9 | 9 |
| 2026: Q1 | 0.04 | – | 58 | 4.60 | 3.90 | 0 | -1 |
- EPS (Earnings Per Share):
- Quarterly profit divided by the total share count — how much of the profit works out to a single share.
- YoY (Year over Year):
- Change versus the same quarter a year ago — this is how you compare without seasonal distortion (e.g. the holiday shopping season).
- Sales:
- All revenue for the quarter, before any costs are deducted — the top line of the income statement.
- Net Margin:
- What percentage of sales is left over as profit in the end. Negative means the company is posting a loss.
- OCF (Operating Cash Flow):
- The cash that actually flows into the till from the core business during the quarter — harder to dress up than book profit.
- FCF (Free Cash Flow):
- Operating cash flow minus capital expenditures — the money that's genuinely free to use, say for paying down debt, buybacks, or dividends.
Assessment: Opportunities & Risks
U.S. dollar life insurance for the emerging-market middle class as protection against devaluation and inflation — established since 1975, policies in over 80 countries, plus a growing final expense business in 43 U.S. states. First year premiums up 71 percent (2024) and 16 percent (2025) to $38.3 million; 2025 brought the second-highest amount of new insurance written in company history (annual report 10-K for 2025).
The company is not licensed as an insurer in any of its foreign markets and has never submitted its international policies to a regulator for approval ("non-admitted", 10-K 2025, Item 1); 64 percent of direct premiums hang on this gray zone. The report itself warns of fines, criminal penalties and market exclusions — plus Venezuela as a top market and a high-risk money laundering jurisdiction per the U.S. Treasury.
Maturity payouts rose to $76.8 million in 2025 (a company record; 2024: $53.6 million; 2023: $41.9 million) and squeeze renewal premiums; the international segment's pre-tax income fell from $23.5 million to $14.4 million. Consolidated net income of $14.6 million sits a third below its 2023 level ($24.4 million) even though revenue grew.
No debt, $1.4 billion of investments (89 percent bonds, yielding 4.67 percent), an Altman Z-score around 3.8, FHLB access as a liquidity reserve; Q1 2026 back in the black at $2.3 million. On the other side: $88.4 million of negative valuation reserve inside equity and a domestic subsidiary (CLOA) barred from distributions in 2026 without special approval (12/31/2025 and data as of July 10, 2026).
A P/E around 18 and price-to-book around 1.3 are no longer a bargain for a niche insurer standing on a gray-zone foundation — after a roughly 70 percent gain in twelve months, part of the rediscovery is already paid for; adjusted for valuation losses (book value $6.43 per share) it is roughly substance price. Also: no dividend, ever; trading volume around $0.5 million a day; 2 trend hits in our in-house stock scanner (data as of July 10, 2026).
Citizens is a genuine curiosity with substance: a debt-free niche machine, 55 years old, selling dollar policies into countries where it has never applied for a license — disclosed, profitable, growing again. Against that stand the contractually fixed endowment payout wave ($76.8 million in 2025, a company record), a profit a third below its 2023 level, political risk from Caracas to Washington, not one dividend in the company's entire history and wafer-thin trading. After a roughly 70 percent price gain in twelve months, this is no longer an undiscovered bargain but a paid-up bet on the durability of a gray zone. Not investment advice.
- CIA reached our research list via the Reddit hype scanner (ApeWisdom, 2 mentions in 24 hours, as of July 15, 2026) — deliberately framed here as an anti-hype finding: despite a 70 percent twelve-month gain, the stock is practically unwatched. The 1 hit in our in-house stock scanner carries the July 10, 2026 data cut-off and rotates daily.
- Scanner metrics (P/E, P/B, relative strength, Piotroski, Altman Z) are computed from trailing twelve-month figures; the Q1 2026 return to profit and the further course of the endowment wave show up in them only with a lag.
- Price and valuation figures are dated to July 10, 2026 (about $6, market value roughly $0.3 billion); analyses are evergreen, daily prices are not a buy argument — and at roughly $0.5 million of daily volume, your own order is itself a price factor.
About the Company
Citizens, Inc. ist ein diversifiziertes Finanzdienstleistungsunternehmen, das Lebens-, Living-Benefits- und Sterbegeldversicherungen sowie andere Finanzprodukte für Privatpersonen und Kleinunternehmen in den USA anbietet.
| Employees | 243 |
|---|---|
| Headquarters | Austin, TX |
| Website | citizensinc.com |
| IPO Date | 5. Dec 1988 |
Management
| Name | Title | Birth Year |
|---|---|---|
| Jon Scott Stenberg | President CEO & Director | 1966 |
| Jeffery Paul Conklin | CFO, Chief Investment Officer & Treasurer | 1970 |
| Sheryl L. Kinlaw J.D. | Chief Legal Officer & Secretary | 1969 |
| Bryon Matthew Lewis | Chief Operating Officer | 1974 |
| Paula Guerrero | Chief Information Officer | 1965 |
| David Scott Jorgensen CPA | General Manager for International Operations of CICA Life Insurance Company of America | 1964 |
| Seth Alan Hoxworth | Chief Actuary | 1986 |
Executives per the latest required filings; titles kept in their original language. Source: fundamental data.
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 14. Jul 2026 | Lewis Bryon Matthew | Chief Operations Officer | Other | 10,697 | 0.00 | – |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character.
View all insider transactions →Chart
Interactive price chart (TradingView).
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.